Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview.

Area of Science:

• Oncology
• Genetics
• Surgical Pathology

Background:

• Colorectal cancer (CRC) is a leading cause of cancer mortality in the US.
• Colorectal liver metastases (CRLM) affect up to 50% of CRC patients.
• Somatic genetic mutations influence CRLM prognosis.

Purpose of the Study:

• To review and appraise current literature on prognostic somatic mutations in surgically treated CRLM.
• To provide recommendations for future research directions.
• To highlight the role of genetic mutations in advancing precision medicine for CRLM.

Main Methods:

• Comprehensive literature review of studies on surgically treated CRLM.
• Analysis of prognostic roles of specific somatic mutations (e.g., RAS, BRAF, MMR, TP53, SMAD4).
• Inclusion of granular data on mutations where available.

Main Results:

• Identified key somatic mutations (RAS, BRAF, MMR, TP53, SMAD4) with prognostic significance in CRLM.
• Highlighted advancements in genetic testing enabling a nuanced understanding of these mutations.
• Emphasized the growing importance of precision medicine in tailoring treatments.

Conclusions:

• Knowledge of CRLM somatic mutations is crucial for personalized treatment strategies.
• Further research is needed to refine our understanding and application of genetic data in CRLM management.
• Precision medicine approaches hold significant promise for improving patient outcomes in CRLM.